ABCB1 and ABCG2 expression in the placenta and fetus: an interspecies comparison

被引:18
作者
Myllynen, Paivi [1 ]
Kummu, Maria [1 ,2 ]
Sieppi, Elina [1 ]
机构
[1] Univ Oulu, Inst Biomed, Dept Pharmacol & Toxicol, FIN-90014 Oulu, Finland
[2] Univ Oulu, Ctr Arctic Med, Thule Inst, FIN-90014 Oulu, Finland
关键词
CANCER RESISTANCE PROTEIN; P-GLYCOPROTEIN EXPRESSION; LIMITS FETAL DISTRIBUTION; MULTIDRUG-RESISTANCE; PHOSPHOGLYCOPROTEIN ABCB1; DRUG TRANSPORTERS; GENE-EXPRESSION; MOUSE PLACENTA; RAT PLACENTA; BCRP/ABCG2;
D O I
10.1517/17425255.2010.514264
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Areas covered in this review: Comprehensive literature searches were done using PubMed (until June 2010) to identify publications on ABCB1 and ABCG2 expression in placenta and fetal tissues in human, mouse, rat, guinea-pig and rabbit. What the reader will gain: In this review, we aim to provide an overview of the current knowledge on the ABCB1 and ABCG2 transporter expression profiles in the placenta and fetal tissues in humans relative to other species. Take home message: The available information on ABCB1 and ABCG2 temporal expression profiles in placenta and fetus indicates rather good correlation among human, mouse and rat although some specific differences have been reported. However, at this point no detailed comparisons or comparative functional data are available. Detailed knowledge on the expression patterns and functional activity of ABCB1 and ABCG2 transporters placenta and developing embryo/fetus in different species could possibly help the interspecies extrapolation.
引用
收藏
页码:1385 / 1398
页数:14
相关论文
共 50 条
  • [41] Hedgehog Pathway Inhibitor HhAntag691 Is a Potent Inhibitor of ABCG2/BCRP and ABCB1/Pgp
    Zhang, Yimao
    Laterra, John
    Pomper, Martin G.
    NEOPLASIA, 2009, 11 (01): : 96 - 101
  • [42] Degree of kinase inhibition achieved in vitro by imatinib and nilotinib is decreased by high levels of ABCB1 but not ABCG2
    Eadie, Laura N.
    Saunders, Verity A.
    Hughes, Timothy P.
    White, Deborah L.
    LEUKEMIA & LYMPHOMA, 2013, 54 (03) : 569 - 578
  • [43] Role of ABCB1, ABCG2, ABCC2 and ABCC5 transporters in placental passage of zidovudine
    Neumanova, Zuzana
    Cerveny, Lukas
    Ceckova, Martina
    Staud, Frantisek
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2016, 37 (01) : 28 - 38
  • [44] Brain Distribution of Dual ABCB1/ABCG2 Substrates Is Unaltered in a Beta-Amyloidosis Mouse Model
    Wanek, Thomas
    Zoufal, Viktoria
    Brackhan, Mirjam
    Krohn, Markus
    Mairinger, Severin
    Filip, Thomas
    Sauberer, Michael
    Stanek, Johann
    Pekar, Thomas
    Pahnke, Jens
    Langer, Oliver
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (21) : 1 - 16
  • [45] Rheumatoid Arthritis Disease Activity Is Determinant for ABCB1 and ABCG2 Drug-Efflux Transporters Function
    Atisha-Fregoso, Yemil
    Lima, Guadalupe
    Pascual-Ramos, Virginia
    Banos-Pelaez, Miguel
    Fragoso-Loyo, Hilda
    Jakez-Ocampo, Juan
    Contreras-Yanez, Irazu
    Llorente, Luis
    PLOS ONE, 2016, 11 (07):
  • [46] Allocrite Sensing and Binding by the Breast Cancer Resistance Protein (ABCG2) and P-Glycoprotein (ABCB1)
    Xu, Yanyan
    Egido, Estefania
    Li-Blatter, Xiaochun
    Mueller, Rita
    Merino, Gracia
    Berneche, Simon
    Seelig, Anna
    BIOCHEMISTRY, 2015, 54 (40) : 6195 - 6206
  • [47] Epertinib counteracts multidrug resistance in cancer cells by antagonizing the drug efflux function of ABCB1 and ABCG2
    Lin, Bing-Huan
    Li, Yen-Ching
    Murakami, Megumi
    Wu, Yu-Shan
    Huang, Yang-Hui
    Hung, Tai-Ho
    Ambudkar, Suresh. V.
    Wu, Chung-Pu
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 180
  • [48] Biological evaluation of non-basic chalcone CYB-2 as a dual ABCG2/ABCB1 inhibitor
    Cai, Chao-Yun
    Zhang, Wei
    Wang, Jing-Quan
    Lei, Zi-Ning
    Zhang, Yun-Kai
    Wang, Yi-Jun
    Gupta, Pranav
    Tan, Cai-Ping
    Wang, Bo
    Chen, Zhe-Sheng
    BIOCHEMICAL PHARMACOLOGY, 2020, 175
  • [49] A comprehensive study of polymorphisms in ABCB1, ABCC2 and ABCG2 and lung cancer chemotherapy response and prognosis
    Campa, Daniele
    Mueller, Phillip
    Edler, Lutz
    Knoefel, Lena
    Barale, Roberto
    Heussel, Claus P.
    Thomas, Michael
    Canzian, Federico
    Risch, Angela
    INTERNATIONAL JOURNAL OF CANCER, 2012, 131 (12) : 2920 - 2928
  • [50] Development of imatinib and dasatinib resistance: dynamics of expression of drug transporters ABCB1, ABCC1, ABCG2, MVP, and SLC22A1
    Gromicho, Marta
    Dinis, Joana
    Magalhaes, Marta
    Fernandes, Alexandra R.
    Tavares, Purificacao
    Laires, Antonio
    Rueff, Jose
    Rodrigues, Antonio Sebastiao
    LEUKEMIA & LYMPHOMA, 2011, 52 (10) : 1980 - 1990